Business Description
Sanofi India Ltd
ISIN : INE058A01010
Share Class Description:
BOM:500674: Ordinary SharesCompare
Compare
Traded in other countries / regions
SANOFI.India IPO Date
1991-03-01Description
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.76 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 451.65 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 19.89 | |||||
| Beneish M-Score | -1.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.6 | |||||
| 3-Year EBITDA Growth Rate | 5.2 | |||||
| 3-Year EPS without NRI Growth Rate | 5.2 | |||||
| 3-Year FCF Growth Rate | -29.9 | |||||
| 3-Year Book Growth Rate | -21.8 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.54 | |||||
| 9-Day RSI | 31.78 | |||||
| 14-Day RSI | 37.7 | |||||
| 6-1 Month Momentum % | 9 | |||||
| 12-1 Month Momentum % | 48.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.92 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.61 | |||||
| Days Inventory | 143.53 | |||||
| Days Sales Outstanding | 16.69 | |||||
| Days Payable | 94.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.1 | |||||
| Dividend Payout Ratio | 0.75 | |||||
| 3-Year Dividend Growth Rate | 22.3 | |||||
| Forward Dividend Yield % | 2.1 | |||||
| 5-Year Yield-on-Cost % | 6.67 | |||||
| Shareholder Yield % | 2.12 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.37 | |||||
| Operating Margin % | 27.25 | |||||
| Net Margin % | 21.4 | |||||
| FCF Margin % | 6.96 | |||||
| ROE % | 59.99 | |||||
| ROA % | 34.23 | |||||
| ROIC % | 63.39 | |||||
| ROC (Joel Greenblatt) % | 217.18 | |||||
| ROCE % | 80.24 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.37 | |||||
| PE Ratio without NRI | 30.94 | |||||
| Shiller PE Ratio | 31.66 | |||||
| Price-to-Owner-Earnings | 69.33 | |||||
| PEG Ratio | 4.3 | |||||
| PS Ratio | 6.5 | |||||
| PB Ratio | 18.04 | |||||
| Price-to-Tangible-Book | 18.17 | |||||
| Price-to-Free-Cash-Flow | 93.38 | |||||
| Price-to-Operating-Cash-Flow | 79.48 | |||||
| EV-to-EBIT | 21.17 | |||||
| EV-to-EBITDA | 20.23 | |||||
| EV-to-Revenue | 6.37 | |||||
| EV-to-FCF | 91.47 | |||||
| Price-to-Projected-FCF | 4.03 | |||||
| Price-to-Median-PS-Value | 1.35 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.13 | |||||
| Price-to-Graham-Number | 5 | |||||
| Price-to-Net-Current-Asset-Value | 33.39 | |||||
| Earnings Yield (Greenblatt) % | 4.72 | |||||
| FCF Yield % | 1.07 | |||||
| Forward Rate of Return (Yacktman) % | 9.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sanofi India Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 28,175 | ||
| EPS (TTM) (₹) | 261.78 | ||
| Beta | 0.37 | ||
| Volatility % | 22.89 | ||
| 14-Day RSI | 37.7 | ||
| 14-Day ATR (₹) | 221.66392 | ||
| 20-Day SMA (₹) | 8331.925 | ||
| 12-1 Month Momentum % | 48.24 | ||
| 52-Week Range (₹) | 6146.05 - 9370.35 | ||
| Shares Outstanding (Mil) | 23.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sanofi India Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sanofi India Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sanofi India Ltd Frequently Asked Questions
What is Sanofi India Ltd(BOM:500674)'s stock price today?
The current price of BOM:500674 is ₹7951.30. The 52 week high of BOM:500674 is ₹9370.35 and 52 week low is ₹6146.05.
When is next earnings date of Sanofi India Ltd(BOM:500674)?
The next earnings date of Sanofi India Ltd(BOM:500674) is 2024-08-09 Est..
Does Sanofi India Ltd(BOM:500674) pay dividends? If so, how much?
The Dividend Yield %  of Sanofi India Ltd(BOM:500674) is 2.1% (As of Today), Highest Dividend Payout Ratio of Sanofi India Ltd(BOM:500674) was 0.79. The lowest was 0.33. And the median was 0.48. The  Forward Dividend Yield % of Sanofi India Ltd(BOM:500674) is 2.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers